Liu FF - Search Results

1

Overview of therapeutic drug research for COVID-19 in China.

Li H, Yang L, Liu FF, Ma XN, He PL, Tang W, Tong XK, Zuo JP. Li H, et al. Among authors: liu ff. Acta Pharmacol Sin. 2020 Sep;41(9):1133-1140. doi: 10.1038/s41401-020-0438-y. Epub 2020 Jun 17. Acta Pharmacol Sin. 2020. PMID: 32555446 Free PMC article. Review.

2

Psoralen inhibits hepatitis B viral replication by down-regulating the host transcriptional machinery of viral promoters.

Ma X, Li H, Gong Y, Liu F, Tong X, Zhu F, Yang X, Yang L, Zuo J. Ma X, et al. Virol Sin. 2022 Apr;37(2):256-265. doi: 10.1016/j.virs.2022.01.027. Epub 2022 Jan 25. Virol Sin. 2022. PMID: 35305922 Free PMC article.

3

Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.

Yang L, Liu F, Tong X, Hoffmann D, Zuo J, Lu M. Yang L, et al. ACS Infect Dis. 2019 May 10;5(5):713-724. doi: 10.1021/acsinfecdis.8b00337. Epub 2019 Mar 29. ACS Infect Dis. 2019. PMID: 30896149 Review.

4

Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors.

Chen W, Liu F, Zhao Q, Ma X, Lu D, Li H, Zeng Y, Tong X, Zeng L, Liu J, Yang L, Zuo J, Hu Y. Chen W, et al. J Med Chem. 2020 Aug 13;63(15):8134-8145. doi: 10.1021/acs.jmedchem.0c00346. Epub 2020 Jul 21. J Med Chem. 2020. PMID: 32692159

5

Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.

Lu D, Liu F, Xing W, Tong X, Wang L, Wang Y, Zeng L, Feng C, Yang L, Zuo J, Hu Y. Lu D, et al. ACS Infect Dis. 2017 Mar 10;3(3):199-205. doi: 10.1021/acsinfecdis.6b00159. Epub 2016 Dec 29. ACS Infect Dis. 2017. PMID: 27989113

6

Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors.

Lu D, Liu J, Zhang Y, Liu F, Zeng L, Peng R, Yang L, Ying H, Tang W, Chen W, Zuo J, Tong X, Liu T, Hu Y. Lu D, et al. Eur J Med Chem. 2018 Feb 10;145:328-337. doi: 10.1016/j.ejmech.2018.01.008. Epub 2018 Jan 5. Eur J Med Chem. 2018. PMID: 29335200

7

CNOT2 facilitates dengue virus infection via negatively modulating IFN-Independent Non-Canonical JAK/STAT pathway.

Liu J, Yang L, Liu F, Li H, Tang W, Tong X, Zuo J. Liu J, et al. Biochem Biophys Res Commun. 2019 Jul 30;515(3):403-409. doi: 10.1016/j.bbrc.2019.05.083. Epub 2019 May 31. Biochem Biophys Res Commun. 2019. PMID: 31155293

8

Flueggenoids A - E, new dinorditerpenoids from Flueggea virosa.

Wang XF, Liu FF, Zhu Z, Fang QQ, Qu SJ, Zhu W, Yang L, Zuo JP, Tan CH. Wang XF, et al. Among authors: liu ff. Fitoterapia. 2019 Mar;133:96-101. doi: 10.1016/j.fitote.2018.12.025. Epub 2018 Dec 31. Fitoterapia. 2019. PMID: 30605781

9

Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy.

Liu F, Yang X, Geng M, Huang M. Liu F, et al. Acta Pharm Sin B. 2018 Jul;8(4):552-562. doi: 10.1016/j.apsb.2018.01.008. Epub 2018 Feb 16. Acta Pharm Sin B. 2018. PMID: 30109180 Free PMC article. Review.

10

BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy.

Wang CJ, Zhu T, Zhao CZ, Cui H, Wang D, Zhao ZJ, Huang XT, Li HL, Liu FF, Zhang R, Li ZG, Cui L. Wang CJ, et al. Among authors: liu ff. Pediatr Blood Cancer. 2024 Jun 6:e31099. doi: 10.1002/pbc.31099. Online ahead of print. Pediatr Blood Cancer. 2024. PMID: 38845144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

677 results

Search Page